JNJ-38158471

CAS: 951151-97-6

Ref. 3D-BNB15197

Produktinformation

• Name: JNJ-38158471

Beschreibung

JNJ-38158471 is a tyrosine kinase inhibitor that has been shown to have anticancer activity. It can be used for the treatment of cancers, including primary resistance. JNJ-38158471 modulates the activity of growth factors, such as vascular endothelial growth factor and hepatocyte growth factor, which are involved in tumor angiogenesis and tumor cell proliferation. This drug also interacts with factor receptors on cells, which may lead to the termination of their signaling pathways. The oral formulation of JNJ-38158471 has been found to be safe and well tolerated in preclinical studies in mice. This drug is also selective for cancer cells, not affecting normal cells.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 364.79 g/mol
• Formel: C₁₅H₁₇ClN₆O₃
• Reinheit: Min. 95%